Agilent Technologies Inc
NYSE:A

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
NYSE:A
Watchlist
Price: 137.95 USD 1.38% Market Closed
Market Cap: 39.1B USD

A's latest stock split occurred on Nov 3, 2014

The company executed a 1398-for-1000 stock split, meaning that for every 1000 shares held, investors received 1398 new shares.

Before the split, A traded at 55.28 per share. Afterward, the share price was about 37.5172.

The adjusted shares began trading on Nov 3, 2014. This was the only stock split in A's history.

Last Splits:
Nov 3, 2014
1398-for-1000
Pre-Split Price
36.325 55.28
Post-Split Price
37.5172
Before
After
Last Splits:
Nov 3, 2014
1398-for-1000

Agilent Technologies Inc
Stock Splits History

A Stock Splits Timeline
Nov 3, 2014
Nov 3, 2014
Split 1398-for-1000
x1.398
Pre-Split Price
36.325 55.28
Post-Split Price
37.5172
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.13 0.13 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.41 8.41 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Dec 30, 2025
Adicet Bio Inc
NASDAQ:ACET
1-for-16
/16
0.4921 0.4921 USD 7.93 7.93 USD
Load More

Agilent Technologies Inc
Glance View

Agilent Technologies Inc., a spin-off from Hewlett-Packard in 1999, has cultivated a niche in the vibrant landscape of the life sciences, diagnostics, and applied chemical markets. This California-based company, born from the legacy of one of Silicon Valley’s pioneers, has carved out its identity by providing sophisticated analytical instrumentation, software, services, and consumables for a wide range of applications. Agilent's businesses are stitched together by an underlying technology expertise, which forms the bedrock for its product lines that serve an increasing demand for precise and reliable analytical measurements. From cutting-edge liquid chromatography to mass spectrometry and genetic analysis systems, Agilent's offerings are geared towards supporting research and quality control processes across various industries, including pharmaceuticals, food safety, and environmental testing. The company's commitment to innovation and quality has consistently positioned it as a trusted partner in advancing the capabilities of laboratories worldwide. Agilent's revenue generation hinges on a strategic blend of product sales and services. The core of its business model revolves around not just selling instruments, but also establishing long-term relationships through service agreements, maintenance, and training. This recurring service revenue complements the sale of consumables and parts required for the operation of their sophisticated instruments. Additionally, Agilent has strategically expanded its footprint in the diagnostics market, providing instruments and reagents used in pathology laboratories, further diversifying its income streams. With a deliberate focus on high-growth areas, including genomics and cancer diagnostics, Agilent continues to leverage its technological prowess and industry expertise to capture market share in sectors that are inherently driven by the necessity for innovation and regulatory compliance. Through an intricate balance of hardware sales and consistent after-sale support, Agilent steadily maintains its role as a formidable player in the analytical instrumentation sector.

A Intrinsic Value
135.19 USD
Overvaluation 2%
Intrinsic Value
Price
Back to Top